11:48 AM EST - Pacgen Biopharmaceuticals Corp. : reported third-quarter net loss of $21,000 or breakeven per share, compared to a loss of $970,000 or $0.03 per share in the same period last year. The net loss narrowed primarily due was largely due to recovery of $746,000 of research and development expenditures and reduced operating expenditures. Pacgen Biopharmaceuticals Corp.
shares V.PGA are trading even at $0.04.
